Saatci, O. Et Al. 2018. Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer. ONCOGENE , vol.37, no.17 , 2251-2269.

Saatci, O., BORGONI, S., Akbulut, O., Durmus, S., Raza, U., Eyupoglu, E., ... Alkan, C.(2018). Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer. ONCOGENE , vol.37, no.17, 2251-2269.

Saatci, Ozge Et Al. "Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer," ONCOGENE , vol.37, no.17, 2251-2269, 2018

Saatci, Ozge Et Al. "Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer." ONCOGENE , vol.37, no.17, pp.2251-2269, 2018

Saatci, O. Et Al. (2018) . "Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer." ONCOGENE , vol.37, no.17, pp.2251-2269.

@article{article, author={Ozge Saatci Et Al. }, title={Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer}, journal={ONCOGENE}, year=2018, pages={2251-2269} }